![Christopher P. Schnittker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher P. Schnittker
Nessuna posizione attualmente
Storia della carriera di Christopher P. Schnittker
Precedenti posizioni note di Christopher P. Schnittker
Società | Posizione | Inizio | Fine |
---|---|---|---|
CANNAPHARMARX, INC. | Comptroller/Controller/Auditor | 09/02/2015 | 18/12/2015 |
Direttore Finanziario/CFO | 12/02/2015 | 18/12/2015 | |
ECHO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 19/05/2011 | 15/07/2014 |
Treasurer | 23/05/2011 | 15/07/2014 | |
VIOQUEST PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 21/07/2008 | 01/07/2009 |
Amgen Rockville, Inc.
![]() Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Direttore Finanziario/CFO | 10/10/2006 | 10/12/2007 |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
![]() Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Direttore Finanziario/CFO | 01/09/2003 | 01/05/2006 |
Genaera Corp.
![]() Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Direttore Finanziario/CFO | 01/08/2003 | 01/08/2003 |
1075 First Global Associates LLC (Pennsylvania)
![]() 1075 First Global Associates LLC (Pennsylvania) Internet RetailRetail Trade 1075 First Global Associates LLC provides e-commerce solutions and marketing services. It offers solutions for its partners through integrated e-commerce platform, which is comprised of three components: core technology, supporting infrastructure, and partner services. The company was founded in 1986 and is headquartered in Wilkes Barre, PA. | Comptroller/Controller/Auditor | 01/06/2000 | 01/06/2000 |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/12/1997 | 01/12/1997 |
Pricewaterhouse LLP | Corporate Officer/Principal | 01/06/1995 | 01/06/1995 |
░░░░░░ ░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Christopher P. Schnittker
Lafayette College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Canada | 2 |
Posizioni
Director of Finance/CFO | 7 |
Comptroller/Controller/Auditor | 3 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
VIOQUEST PHARMACEUTICALS, INC. | Health Technology |
SOLIGENIX, INC. | Health Technology |
CANNAPHARMARX, INC. | Process Industries |
Aziende private | 8 |
---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
![]() Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Amgen Rockville, Inc.
![]() Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Genaera Corp.
![]() Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Echo Therapeutics, Inc.
![]() Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Pricewaterhouse LLP | Commercial Services |
1075 First Global Associates LLC (Pennsylvania)
![]() 1075 First Global Associates LLC (Pennsylvania) Internet RetailRetail Trade 1075 First Global Associates LLC provides e-commerce solutions and marketing services. It offers solutions for its partners through integrated e-commerce platform, which is comprised of three components: core technology, supporting infrastructure, and partner services. The company was founded in 1986 and is headquartered in Wilkes Barre, PA. | Retail Trade |
Golden Dragon Holding Co.
![]() Golden Dragon Holding Co. Financial ConglomeratesFinance Golden Dragon Holding Co. operates as a shell company. It intends to seek, investigate and acquire an interest in business opportunities. The company was founded in August 1998 and is headquartered in Denver, CO. | Finance |